Longer leukocyte telomere length is associated with myeloid inflammation and increased mortality after transcatheter aortic valve replacement.

Inflammation Leukocytes TAVR Telomeres

Journal

European heart journal open
ISSN: 2752-4191
Titre abrégé: Eur Heart J Open
Pays: England
ID NLM: 9918282081406676

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 16 02 2022
revised: 09 05 2022
entrez: 19 8 2022
pubmed: 20 8 2022
medline: 20 8 2022
Statut: epublish

Résumé

Inflammatory activation of leukocytes may limit prognosis of patients (pts) with severe aortic valve stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR). Leukocyte telomere length (LTL) is a marker of proliferative capacity and inflammatory responsiveness but the impact of LTL on the prognosis in AS remains elusive. The aim of this study was to analyse the association of LTL with inflammatory markers and prognosis of pts undergoing TAVR. LTL was analysed using quantitative real-time PCR in 285 consecutive pts (median age 82 years) undergoing TAVR and correlated with 18-month all-cause mortality. C-reactive protein was significantly elevated in pts with the longest LTL ( Longer LTL is associated with increased mortality after TAVR. This might be explained by enhanced proliferative capacity of cells resulting in myeloid and systemic inflammation. Our findings suggest that targeting the specific inflammation pathways could present a novel strategy to augment survival in selected patients with degenerative aortic stenosis.

Identifiants

pubmed: 35983406
doi: 10.1093/ehjopen/oeac045
pii: oeac045
pmc: PMC9380992
doi:

Types de publication

Journal Article

Langues

eng

Pagination

oeac045

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

EBioMedicine. 2015 Jul 29;2(10):1549-58
pubmed: 26629551
Eur Heart J. 2020 Feb 21;41(8):933-939
pubmed: 31504400
Aging (Albany NY). 2018 Oct 29;10(10):3005-3016
pubmed: 30375983
Eur Heart J. 2021 Aug 7;42(30):2912-2919
pubmed: 34179981
FASEB J. 2004 Feb;18(2):418-20
pubmed: 14688198
Sci Adv. 2022 Apr 8;8(14):eabl6579
pubmed: 35385311
ESC Heart Fail. 2020 Oct;7(5):2597-2610
pubmed: 32639677
PLoS One. 2019 Mar 12;14(3):e0213250
pubmed: 30861019
Circulation. 2020 Sep 15;142(11):1092-1105
pubmed: 32697107
Circulation. 2009 Oct 6;120(14):1364-72
pubmed: 19770396
Eur Heart J. 2012 Jun;33(12):1459-68
pubmed: 22285582
Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):1047-1061
pubmed: 33504179

Auteurs

Jedrzej Hoffmann (J)

Department of Medicine, Cardiology, Goethe University Hospital, Frankfurt, Germany.

Noriaki Tabata (N)

Department of Medicine II, Heart Center Bonn, University Hospital Bonn, Bonn, Germany.

Silvia Mas-Peiro (S)

Department of Medicine, Cardiology, Goethe University Hospital, Frankfurt, Germany.

Ioakim Spyridopoulos (I)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Jan-Malte Sinning (JM)

Department of Medicine II, Heart Center Bonn, University Hospital Bonn, Bonn, Germany.

Alexander Berkowitsch (A)

Department of Medicine, Cardiology, Goethe University Hospital, Frankfurt, Germany.

Carmen Martin-Ruiz (C)

Newcastle University Bioscience Institute, Newcastle University, Newcastle upon Tyne, UK.

Baravan Al-Kassou (B)

Department of Medicine II, Heart Center Bonn, University Hospital Bonn, Bonn, Germany.

Eva Herrmann (E)

German Center for Cardiovascular Research DZHK, Partner Site Rhine-Main, Berlin, Germany.

Stefanie Dimmeler (S)

Institute of Cardiovascular Regeneration, Center of Molecular Medicine, Goethe University Frankfurt, Germany.

Andreas M Zeiher (AM)

Department of Medicine, Cardiology, Goethe University Hospital, Frankfurt, Germany.

Mariuca Vasa-Nicotera (M)

Department of Medicine, Cardiology, Goethe University Hospital, Frankfurt, Germany.

Classifications MeSH